Clinical Trial Update: Study Investigating Enbrel Treatment for Ankylosing Spondylitis

View source ↗

Summary

The clinical trial evaluating Enbrel (etanercept) for ankylosing spondylitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Ankylosing Spondylitis | Status: COMPLETED